1
|
Yang J, Yang J, Gao Y, Zhao L, Liu L, Qin
Y, Wang X, Song T and Huang C: Identification of potential serum
proteomic biomarkers for clear cell renal cell carcinoma. PLoS One.
9:e1113642014. View Article : Google Scholar : PubMed/NCBI
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
3
|
Lasseigne BN, Burwell TC, Patil MA, Absher
DM, Brooks JD and Myers RM: DNA methylation profiling reveals novel
diagnostic biomarkers in renal cell carcinoma. BMC Med. 12:2352014.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Janowitz T, Welsh SJ, Zaki K, Mulders P
and Eisen T: Adjuvant therapy in renal cell carcinoma - past,
present, and future. Semin Oncol. 40:482–491. 2013. View Article : Google Scholar : PubMed/NCBI
|
5
|
Li W, Liu M, Xu YF, Feng Y, Che JP, Wang
GC and Zheng JH: Combination of quercetin and hyperoside has
anticancer effects on renal cancer cells through inhibition of
oncogenic microRNA-27a. Oncol Rep. 31:117–124. 2014.PubMed/NCBI
|
6
|
Zhang HM, Yang FQ, Yan Y, Che JP and Zheng
JH: High expression of long non-coding RNA SPRY4-IT1 predicts poor
prognosis of clear cell renal cell carcinoma. Int J Clin Exp
Pathol. 7:5801–5809. 2014.PubMed/NCBI
|
7
|
Bouyain S and Leahy DJ: Structure-based
mutagenesis of the substrate-recognition domain of Nrdp1/FLRF
identifies the binding site for the receptor tyrosine kinase ErbB3.
Protein Sci. 16:654–661. 2007. View Article : Google Scholar : PubMed/NCBI
|
8
|
Meroni G and Diez-Roux G: TRIM/RBCC, a
novel class of ‘single protein RING finger’ E3 ubiquitin ligases.
Bioessays. 27:1147–1157. 2005. View Article : Google Scholar : PubMed/NCBI
|
9
|
Qiu XB and Goldberg AL: Nrdp1/FLRF is a
ubiquitin ligase promoting ubiquitination and degradation of the
epidermal growth factor receptor family member, ErbB3. Proc Natl
Acad Sci USA. 99:14843–14848. 2002. View Article : Google Scholar : PubMed/NCBI
|
10
|
Yen L, Cao Z, Wu X, Ingalla ER, Baron C,
Young LJ, Gregg JP, Cardiff RD, Borowsky AD, Sweeney C and Carraway
KL III: Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor
cell growth. Cancer Res. 66:11279–11286. 2006. View Article : Google Scholar : PubMed/NCBI
|
11
|
Lu H, Li H, Mao D, Zhu Z and Sun H: Nrdp1
inhibits growth of colorectal cancer cells by nuclear retention of
p27. Tumour Biol. 35:8639–8643. 2014. View Article : Google Scholar : PubMed/NCBI
|
12
|
Qiu XB, Markant SL, Yuan J and Goldberg
AL: Nrdp1-mediated degradation of the gigantic IAP, BRUCE, is a
novel pathway for triggering apoptosis. EMBO J. 23:800–810. 2004.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Yu F and Zhou J: Parkin is ubiquitinated
by Nrdp1 and abrogates Nrdp1-induced oxidative stress. Neurosci
Lett. 440:4–8. 2008. View Article : Google Scholar : PubMed/NCBI
|
14
|
Wang C, Chen T, Zhang J, Yang M, Li N, Xu
X and Cao X: The E3 ubiquitin ligase Nrdp1 ‘preferentially’
promotes TLR-mediated production of type I interferon. Nat Immunol.
10:744–752. 2009. View
Article : Google Scholar : PubMed/NCBI
|
15
|
Chen Z, Naito M, Hori S, Mashima T, Yamori
T and Tsuruo T: A human IAP-family gene, apollon, expressed in
human brain cancer cells. Biochem Biophys Res Commun. 264:847–854.
1999. View Article : Google Scholar : PubMed/NCBI
|
16
|
Bartke T, Pohl C, Pyrowolakis G and
Jentsch S: Dual role of BRUCE as an antiapoptotic IAP and a
chimeric E2/E3 ubiquitin ligase. Mol Cell. 14:801–811. 2004.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Qiu XB and Goldberg AL: The
membrane-associated inhibitor of apoptosis protein, BRUCE/Apollon,
antagonizes both the precursor and mature forms of Smac and
caspase-9. J Biol Chem. 280:174–182. 2005. View Article : Google Scholar : PubMed/NCBI
|
18
|
Hao Y, Sekine K, Kawabata A, Nakamura H,
Ishioka T, Ohata H, Katayama R, Hashimoto C, Zhang X, Noda T, et
al: Apollon ubiquitinates SMAC and caspase-9, and has an essential
cytoprotection function. Nat Cell Biol. 6:849–860. 2004. View Article : Google Scholar : PubMed/NCBI
|
19
|
Shi H, Du J, Wang L, Zheng B, Gong H, Wu
Y, Tang Y, Gao Y and Yu R: Lower expression of Nrdp1 in human
glioma contributes tumor progression by reducing apoptosis. IUBMB
Life. 66:704–710. 2014. View
Article : Google Scholar : PubMed/NCBI
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Valsechi MC, Oliveira AB, Conceição AL,
Stuqui B, Candido NM, Provazzi PJ, de Araújo LF, Silva WA Jr,
Calmon Mde F and Rahal P: GPC3 reduces cell proliferation in renal
carcinoma cell lines. BMC Cancer. 14:6312014. View Article : Google Scholar : PubMed/NCBI
|
22
|
Qiao HP, Gao WS, Huo JX and Yang ZS: Long
non-coding RNA GAS5 functions as a tumor suppressor in renal cell
carcinoma. Asian Pac J Cancer Prev. 14:1077–1082. 2013. View Article : Google Scholar : PubMed/NCBI
|
23
|
Zhang T, Zheng J, Jiang N, Wang G, Shi Q,
Liu C and Lu Y: Overexpression of DLC-1 induces cell apoptosis and
proliferation inhibition in the renal cell carcinoma. Cancer Lett.
283:59–67. 2009. View Article : Google Scholar : PubMed/NCBI
|
24
|
Hu G, Lai P, Liu M, Xu L, Guo Z, Liu H, Li
W, Wang G, Yao X, Zheng J and Xu Y: MiR-203a regulates
proliferation, migration, and apoptosis by targeting glycogen
synthase kinase-3β in human renal cell carcinoma. Tumour Biol.
35:11443–11453. 2014. View Article : Google Scholar : PubMed/NCBI
|
25
|
Hassan M, Watari H, AbuAlmaaty A, Ohba Y
and Sakuragi N: Apoptosis and molecular targeting therapy in
cancer. Biomed Res Int. 2014:1508452014. View Article : Google Scholar : PubMed/NCBI
|
26
|
Wong RS: Apoptosis in cancer: From
pathogenesis to treatment. J Exp Clin Cancer Res. 30:872011.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Bartke T, Pohl C, Pyrowolakis G and
Jentsch S: Dual role of BRUCE as an antiapoptotic IAP and a
chimeric E2/E3 ubiquitin ligase. Mol Cell. 14:801–811. 2004.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Ren J, Shi M, Liu R, Yang QH, Johnson T,
Skarnes WC and Du C: The Birc6 (Bruce) gene regulates p53 and the
mitochondrial pathway of apoptosis and is essential for mouse
embryonic development. Proc Natl Acad Sci USA. 102:565–570. 2005.
View Article : Google Scholar : PubMed/NCBI
|